Resources

Past Presentation

GLP-1 Agonists for Alcohol Use Disorder | March 5, 2025

Date of Presentation: March 5, 2025

Type: Past Presentation  

Program: Hepatitis C  

Keywords: #agonists  #alcohol use disorder  #GLP-1  

In this presentation, Dr. Jasen Christensen, DO, reviews three recent studies on the use of GLP-1 agonists for Alcohol Use Disorder including a focus on exenatide, dulaglutide, and semaglutide.

Presented by:

Dr. Jasen Christensen, DO

Dr. Jasen Christensen, DO, is an associate professor and psychiatrist in the Department of Psychiatry and Behavioral Sciences at the University of New Mexico School of Medicine.Dr. Christensen received undergraduate degrees in Cellular/Molecular Biology and German Language from Humboldt State University (now Cal Poly Humboldt) in 1999. He earned the degree of Doctor of Osteopathic Medicine at Western University of Health Sciences in 2006. He completed a residency in psychiatry at the University of New Mexico in 2010. His past work in psychiatry has included positions with the US Public Health Service (at an IHS service unit), inpatient and PES at a county psychiatric hospital, and integrated psychiatry at a community health center (FQHC). He is board certified in psychiatry (ABPN) and addiction medicine (ABPM).

Resources Provided:

Date added: March 5, 2025